Biological interferon assay.

JF Junjie Feng
AW Arthur Wickenhagen
MT Matthew L. Turnbull
VR Veronica V. Rezelj
FK Felix Kreher
NT Natasha L. Tilston-Lunel
GS Gillian S. Slack
BB Benjamin Brennan
EK Elina Koudriakova
AS Andrew E. Shaw
SR Suzannah J. Rihn
CR Charles M. Rice
PB Paul D. Bieniasz
RE Richard M. Elliott
XS Xiaohong Shi
SW Sam J. Wilson
request Request a Protocol
ask Ask a question
Favorite

The biological assay for IFN production was performed as described previously (73). Briefly, “IFN-competent” HeLa cells were infected with different BUNV mutants (MOI = 3) and incubated at 37°C for 24 h. The supernatant was clarified by a brief centrifugation and inactivated by UV irradiation. The UV-inactivated supernatant was 2-fold serially diluted and used to treat “IFN-incompetent” A549-Npro cells (expressing the bovine viral diarrhea virus NPro protein). Cells were infected with encephalomyocarditis virus (EMCV) at an MOI of 0.01, fixed with 8% formaldehyde, and stained with a methyl violet staining solution (5% [wt/vol]).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A